The global bioreactors market size is likely to project a CAGR of 16.3% during the forecast years 2021-2028. A bioreactor is a vessel in which a chemical reaction involving organisms or biochemically active chemicals obtained from organisms is carried out. It is used in industrial processes to produce pharmaceuticals, vaccines, or antibodies.

The present and future bioreactors market progress is summarized to conclude the attractiveness of the entire market. The growth of market is ascribed to strong focus on new drug development by biotechology and pharmaceutical companies along with increase in research outsourcing to contract research organizations.

Adroit Market Research report on global bioreactors market gives a holistic view of the market, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for the period 2019 to 2028, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global bioreactors market have been studied in detail.

Based on type, the global bioreactors market is categorized into single-use bioreactors an multi-use bioreactors. The multi-use bioreactors segment seized the two-third market share of in 2020 and it is likely to maintain its place throughout the forecast years. Single-use bioreactors segment is anticipated to witness lucrative growth during the forecast years owing to high flexibility in terms of usage, less downtime, and controlled microbial contamination by single-use bioreactors. By application, the global bioreactors market is categorized into biotechnology and pharmaceutical, contract research organizations (CROs), and others. Contract research organizations (CROs) is projected to witness fastest growth rate over the forecast period.

North America dominated the global bioreactors market in 2020. However, by 2028, Asia Pacific is expected to be a lucrative bioreactors market. Over the next few years, the consumption of biopharmaceutical products is predicted to skyrocket throughout the region. As a result, the manufacturing procedures for these products must be able to match market demand. There has been a huge surge in foreign investments in the Asia Pacific biopharmaceutical sector. The companies have high hopes for Asia, owing to increased development costs, and a need for biotech talent. The region boasts a diverse pharmaceutical manufacturing base, lower manufacturing costs, and accelerated clinical development.

The major players of the global bioreactors market Sartorius AG, Merck KGaA, Thermo Fisher Scientific, Danaher Corporation, Eppendorf AG, ZETA, Infors HT, Solaris Biotech, and Spar Mixers among other prominent players. Multi-parallel bioreactors and single-use bioreactors are a few of the products offered by these players in the global market.

Key Segments of the Global Bioreactors Market

Product Overview, 2019-2028 (USD Billion)

• Single-use Bioreactors
• Multi-use Bioreactors

Application Overview, 2019-2028 (USD Billion)

• Biotechnology & Pharmaceutical
• Contract Research Organizations (CROs)
• Others

Cosntruction Material Overview, 2019-2028 (USD Billion)

• Stainless Steel
• Glass
• Others

Regional Overview, 2019-2028 (USD Billion)

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• Rest of Asia Pacific

South America

• Brazil
• Mexico
• Rest of South America

Middle East and Africa

• GCC
• South Africa
• Rest of Middle East and Africa